Disposition of 266 shares by Walker Saik of Pool at 471.87 subject to Rule 16b-3
| BINP Stock | USD 0.27 0.02 8.00% |
Slightly above 57% of all Bionoid Pharma's retail investors are looking to take a long position. The analysis of overall sentiment of trading Bionoid Pharma pink sheet suggests that some investors are interested at this time. Bionoid Pharma's investing sentiment overview a quick insight into current market opportunities from investing in Bionoid Pharma. Many technical investors use Bionoid Pharma stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Bionoid |
Filed transaction by Pool Corporation Officer: Corporate Controller. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Bionoid Pharma Fundamental Analysis
We analyze Bionoid Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bionoid Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bionoid Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Gross Profit
Gross Profit Comparative Analysis
Bionoid Pharma is currently under evaluation in gross profit category among its peers. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Bionoid Pharma Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bionoid Pharma pink sheet to make a market-neutral strategy. Peer analysis of Bionoid Pharma could also be used in its relative valuation, which is a method of valuing Bionoid Pharma by comparing valuation metrics with similar companies.
Peers
Bionoid Pharma Related Equities
| WNW | Meiwu Technology | 9.23 | ||||
| GTY | Getty Realty | 0.37 | ||||
| FRCOF | Fast Retailing | 0.00 | ||||
| CNLFF | Canlan Ice | 0.00 | ||||
| HOFT | Hooker Furniture | 0.17 | ||||
| SSY | SunLink Health | 1.20 | ||||
| POOL | Pool | 2.22 | ||||
| GO | Grocery Outlet | 2.91 |
Additional Tools for Bionoid Pink Sheet Analysis
When running Bionoid Pharma's price analysis, check to measure Bionoid Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionoid Pharma is operating at the current time. Most of Bionoid Pharma's value examination focuses on studying past and present price action to predict the probability of Bionoid Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionoid Pharma's price. Additionally, you may evaluate how the addition of Bionoid Pharma to your portfolios can decrease your overall portfolio volatility.